目的　评价熊胆胶囊对病毒性肝炎的治疗作用。方法　78例急、慢性病毒性肝炎患者采用熊胆胶囊口服治疗,并以复方益肝灵治疗23例急、慢性肝炎患者作为对照。4周后对其效果进行评价。结果　熊胆胶囊治疗组总胆红素复常率为81%,而复方益肝灵治疗组则为40%;两组的降酶效果均较显著,转氨酶复常率接近80%。治疗过程中均无明显的不良反应。结论　熊胆胶囊对病毒性肝炎患者有较好的治疗作用。 Objective To evaluate the therapeutic effect of Xiong Dan capsule on viral hepatitis. Methods 78 patients with acute and chronic viral hepatitis were treated with Xiong Dan Capsule orally, and 23 patients with acute and chronic hepatitis were treated with compound Yiganling as control. After 4 weeks its effect was evaluated. Results The recovery rate of total bilirubin in Xiong Dan Capsule group was 81%, while that in Compound Yiganling group was 40%. The reducing effect of both groups was significant, and the normal rate of aminotransferase was close to 80%. No significant adverse reactions during treatment. Conclusion Xiong Dan capsule in patients with viral hepatitis has a better therapeutic effect.